Folate receptor-α expression in resectable hepatic colorectal cancer metastases: patterns and significance

被引:42
作者
D'Angelica, Michael [2 ]
Ammori, John [2 ]
Gonen, Mithat [3 ]
Klimstra, David S. [1 ]
Low, Philip S. [4 ,5 ]
Murphy, Linda [6 ]
Weiser, Martin R. [2 ]
Paty, Philip B. [2 ]
Fong, Yuman [2 ]
DeMatteo, Ronald P. [2 ]
Allen, Peter [2 ]
Jarnagin, William R. [2 ]
Shia, Jinru [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Biostat, New York, NY 10021 USA
[4] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA
[5] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA
[6] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN USA
关键词
folate receptor 1 (adult); folate-targeted therapy; liver metastasis; THYMIDYLATE SYNTHASE EXPRESSION; MICROSATELLITE INSTABILITY; MOLECULAR MARKERS; OVARIAN-CANCER; SURVIVAL; P53; RECURRENCE; PROGNOSIS; RESECTION; MUTATION;
D O I
10.1038/modpathol.2011.82
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Folate receptor alpha (FR alpha), encoded by folate receptor 1 (adult) gene, has emerged as a cancer biomarker and potential therapeutic target. In addition, its expression in tumors may offer prognostic information. The aim of this study was to assess the prognostic value of FR alpha expression and other common molecular markers in resected liver metastases from colorectal cancer. To maximize potential biological differences, we selected two groups of patients with markedly different outcomes as study subjects. Immunohistochemical analysis of FR alpha expression and other common markers (thymidylate synthase, p53, p27, BCL2, ki67, MLH1, MSH2 and MGMT) on tissue microarrays was carried out on samples from 160 patients; 56 patients survived at least 10 years following liver resection, and 104 died within 2 years of surgery. These markers were evaluated and compared with standard clinical predictors of outcome including a previously validated clinical risk score. Our results showed that in addition to known clinical risk factors, FR alpha positivity was significantly associated with the early death group (32% compared with 13%; P=0.03). None of the other common molecular markers were differentially expressed between the two groups. On multivariate analysis, clinical risk score, margin status and FR alpha expression were independently associated with outcome. Specific multivariate comparisons confirmed that FR alpha expression was associated with outcome independent of the clinical risk score and margin. These data demonstrate that FR alpha expression is present in a subset of resected hepatic colorectal cancer metastases, and this marker is independently associated with survival after hepatic resection. The prognostic value of FR alpha expression and the utility of FR alpha-targeted therapies in stage-IV colorectal cancer patients deserve further exploration. Modern Pathology (2011) 24, 1221-1228; doi:10.1038/modpathol.2011.82; published online 13 May 2011
引用
收藏
页码:1221 / 1228
页数:8
相关论文
共 35 条
[1]   Improving resectability of hepatic colorectal metastases: Expert consensus statement [J].
Abdalla, Eddie K. ;
Adam, Rene ;
Bilchik, Anton J. ;
Jaeck, Daniel ;
Vauthey, Jean-Nicolas ;
Mahvi, David .
ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (10) :1271-1280
[2]   Functional Folate Receptor Alpha Is Elevated in the Blood of Ovarian Cancer Patients [J].
Basal, Eati ;
Eghbali-Fatourechi, Guiti Z. ;
Kalli, Kimberly R. ;
Hartmann, Lynn C. ;
Goodman, Karin M. ;
Goode, Ellen L. ;
Kamen, Barton A. ;
Low, Philip S. ;
Knutson, Keith L. .
PLOS ONE, 2009, 4 (07)
[3]   Folate and carcinogenesis: An integrated scheme [J].
Choi, SW ;
Mason, JB .
JOURNAL OF NUTRITION, 2000, 130 (02) :129-132
[4]   Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer - Analysis of 1001 consecutive cases [J].
Fong, Y ;
Fortner, J ;
Sun, RL ;
Brennan, MF ;
Blumgart, LH .
ANNALS OF SURGERY, 1999, 230 (03) :309-318
[5]   Thymidylate synthase expression in hepatic tumors is a predictor of survival and progression in patients with resectable metastatic colorectal cancer [J].
Gonen, M ;
Hummer, A ;
Zervouclakis, A ;
Sullivan, D ;
Fong, Y ;
Banerjee, D ;
Klimstra, D ;
Cordon-Cardo, C ;
Bertino, J ;
Kemeny, N .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (03) :406-412
[6]   Folate receptor overexpression is associated with poor outcome in breast cancer [J].
Hartmann, Lynn C. ;
Keeney, Gary L. ;
Lingle, Wilma L. ;
Christianson, Teresa J. H. ;
Varghese, Bindu ;
Hillman, David ;
Oberg, Ann L. ;
Low, Philip S. .
INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (05) :938-942
[7]  
HENDERSON GB, 1990, ANNU REV NUTR, V10, P319, DOI [10.1146/annurev.nutr.10.1.319, 10.1146/annurev.nu.10.070190.001535]
[8]   Expression status of folate receptor α is significantly correlated with prognosis in non-small-cell lung cancers [J].
Iwakiri, Shotaro ;
Sonobe, Makoto ;
Nagai, Shinjiro ;
Hirata, Toshiki ;
Wada, Hiromi ;
Miyahara, Ryo .
ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (03) :889-899
[9]   Rationale for folate receptor alpha targeted therapy in "high risk" endometrial carcinomas [J].
Jones, Monica Brown ;
Neuper, Christina ;
Clayton, Amy ;
Mariani, Andrea ;
Konecy, Gottfried ;
Thomas, M. Bijoy ;
Keeney, Gary ;
Hartmann, Lynn ;
Podratz, Karl C. .
INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (07) :1699-1703
[10]  
Kularatne SA, 2010, METHODS MOL BIOL, V624, P249, DOI 10.1007/978-1-60761-609-2_17